Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
PI4P and GNE-6468 Rewire STING Activation
2026-09-22
A 2026 Immunity study shows that the Golgi lipid PI4P cooperates with the chemical agonist GNE-6468 to activate STING through transmembrane-helix rearrangement rather than by changing the canonical ligand-binding domain. Cryo-EM and functional experiments connect this structural mechanism to STING oligomerization and antiviral and antitumor immune responses, providing a framework for mechanism-guided agonist research.
-
Bazedoxifene in ER and IL-6/GP130 Research
2026-09-22
Bazedoxifene supports a dual-track research strategy: conventional estrogen receptor assays for osteoporosis biology and pathway-focused studies of IL-6/GP130 signaling in cancer models. This guide connects compound handling, dose design, orthogonal readouts, and troubleshooting for more reproducible translational experiments.
-
DAPI for PAD4–NETs Translational Research
2026-09-21
DAPI is more than a blue nuclear counterstain: when integrated with chromatin, apoptosis, and immune-microenvironment assays, it can help translational researchers interpret PAD4–H3cit–NET biology. This article outlines how DAPI Solution (1 mg/mL) can strengthen mechanistic validation while clarifying what the stain can—and cannot—establish.
-
Gamithromycin PK/PD Workflows for Respiratory Models
2026-09-21
Gamithromycin (ML-1709460) supports serum-aware susceptibility testing, lung infection models, and PK/PD analyses centered on AUC24h/MIC. This guide translates published Pasteurella multocida findings into practical workflows for veterinary respiratory research while highlighting formulation, matrix, and interpretation pitfalls.
-
MK 0893: From Allostery to Translational Strategy
2026-09-20
MK 0893 shows how an extra-helical glucagon receptor binding site can connect structural pharmacology with reproducible type 2 diabetes research. This article translates its mechanism, assay profile, selectivity boundaries, and in vivo evidence into a practical strategy for translational researchers.
-
MK-571: Decoding Receptor and MRP1 Biology
2026-09-19
MK-571 (L-660,711) is a high-affinity cysLT1 antagonist and MRP1 probe for separating leukotriene signaling from transporter-dependent macrophage protection. This guide translates its pharmacology into assay decisions for airway inflammation, asthma research, and chemotherapeutic stress models.
-
Amiloride (MK-870) Workflows for Ion Transport
2026-09-18
Amiloride (MK-870) provides a reversible way to interrogate ENaC-, PC2-, and uPAR-associated biology in epithelial and uptake assays. This practical guide connects concentration-controlled perturbation, electrophysiology, transport measurements, and translational study design without treating an inhibitor result as proof of pathway specificity.
-
Gastrin I (human) in Reliable GI Assays
2026-09-18
This scenario-based guide shows how Gastrin I (human), SKU B5358, can support controlled CCK2-receptor, gastric acid secretion, organoid, and cell-response experiments. It emphasizes model selection, DMSO compatibility, peptide handling, orthogonal interpretation, and supplier-quality checks.
-
Luminescent ATP Detection Assay Kit in NSCLC
2026-09-17
Use the Luminescent ATP Detection Assay Kit to connect pyruvate carboxylase biology with measurable cellular energy changes in NSCLC models. Its firefly luciferase ATP assay chemistry supports sensitive cell and tissue workflows while preserving material for protein-based validation.
-
NETs, MD-1, and Unstable Carotid Plaques
2026-09-17
This study identifies a mechanistic circuit in which soluble MD-1/LY86 stimulates neutrophil extracellular trap formation, promotes intraplaque neovascularization, and feeds back through macrophages to amplify plaque instability. Its combination of bioinformatics, patient-derived samples, and endothelial and immune-cell experiments provides a framework for investigating inflammatory signal pathway suppression in vulnerable carotid atherosclerosis.
-
MLKL Polymerization and Lysosomal LMP in Necroptosis
2026-09-16
The reference study identifies lysosomal membrane permeabilization as a key execution step in MLKL-driven necroptosis. It shows that polymerized MLKL reaches lysosomal membranes, promotes lysosome clustering and permeabilization, and releases cathepsin B, linking organelle damage to downstream cell death.
-
DNA Damage Drives Selective CUX2 Neuron Loss
2026-09-16
The reference study identifies DNA damage burden and inadequate repair as drivers of selective CUX2-positive layer 2/3 excitatory neuron loss during neuroinflammation. By integrating human multiple sclerosis tissue with mouse and cellular models, it connects interferon-γ-induced oxidative stress to neuronal vulnerability and highlights CUX2 and ATF4-dependent repair as determinants of resilience.
-
HyperFluor 488 Goat Anti-Rabbit IgG Guide
2026-09-15
HyperFluor™ 488 Goat Anti-Rabbit IgG (H+L) Antibody provides fluorescent detection of rabbit primary antibodies in immunofluorescence, immunocytochemistry, fluorescent immunohistochemistry, microscopy, and validated flow-cytometry workflows. It is intended for fixed-sample or otherwise validated applications; do not assume suitability for live-cell labeling or untested assay formats because the supplied buffer contains sodium azide.
-
Novel Allosteric PDK4 Inhibitors: Study Analysis
2026-09-15
This 2019 Journal of Medicinal Chemistry study developed anthraquinone-derived allosteric inhibitors of pyruvate dehydrogenase kinase 4, identifying compound 8c with nanomolar in vitro activity. Its integrated medicinal chemistry, pharmacokinetic, docking, cellular, and animal-model strategy supports PDK4 as a drug-discovery target while emphasizing the limits of translating preclinical metabolic findings.
-
MK-571 (L-660,711) Assay Workflow Guide
2026-09-14
MK-571 (L-660,711) is a dual-purpose tool for separating cysteinyl leukotriene signaling from MRP1/ABCC1-linked transport effects. This workflow translates its receptor pharmacology and macrophage chemoprotection applications into practical assay design, dosing, controls, and troubleshooting steps.